BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29625856)

  • 21. [Unclear Abdominal Pain - Not Always a Gastroenterological Emergency].
    Aschoff AT; Pech M; Fischbach F; Ricke J; Luani B; Braun-Dullaeus RC; Herold J
    Dtsch Med Wochenschr; 2017 Apr; 142(7):530-533. PubMed ID: 28388751
    [No Abstract]   [Full Text] [Related]  

  • 22. Ultrasound therapy in rectus sheath hematoma.
    Berná-Serna JD; Sánchez-Garre J; Madrigal M; Zuazu I; Berná-Mestre JD
    Phys Ther; 2005 Apr; 85(4):352-7. PubMed ID: 15794705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the prothrombin complex concentrate prothromplex in patients requiring urgent reversal of vitamin K antagonists or presenting with uncontrolled bleeding: a retrospective, single center study.
    Leal-Noval SR; López-Irizo R; Bautista-Paloma J; Casado M; Arellano-Orden V; Leal-Romero M; Fernández-Hinojosa E; Puppo-Moreno A; Muñoz M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):862-8. PubMed ID: 24060736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists.
    van Rein N; Lijfering WM; Bos MH; Herruer MH; Vermaas HW; van der Meer FJ; Reitsma PH
    PLoS One; 2016; 11(12):e0164485. PubMed ID: 27935941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K antagonists and emergencies.
    Lapostolle F; Siguret V; Martin AC; Pailleret C; Vigué B; Zerbib Y; Tazarourte K
    Eur J Emerg Med; 2018 Dec; 25(6):378-386. PubMed ID: 29462053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Method agreement analysis and interobserver reliability of the ISTH proposed definitions for effective hemostasis in management of major bleeding.
    Abdoellakhan RA; Beyer-Westendorf J; Schulman S; Sarode R; Meijer K; Khorsand N
    J Thromb Haemost; 2019 Mar; 17(3):499-506. PubMed ID: 30657628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study.
    Yoshimura S; Sato S; Todo K; Okada Y; Furui E; Matsuki T; Yamagami H; Koga M; Takahashi JC; Nagatsuka K; Arihiro S; Toyoda K;
    J Neurol Sci; 2017 Apr; 375():150-157. PubMed ID: 28320118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis.
    Brekelmans MPA; Ginkel KV; Daams JG; Hutten BA; Middeldorp S; Coppens M
    J Thromb Thrombolysis; 2017 Jul; 44(1):118-129. PubMed ID: 28540468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four-factor prothrombin complex concentrate versus plasma for urgent vitamin K antagonist reversal: new evidence.
    Sarode R
    Clin Lab Med; 2014 Sep; 34(3):613-21. PubMed ID: 25168946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spontaneous rectus sheath hematoma: a rare condition with uneasy diagnosis and multidisciplinary treatment. Report of 5 cases and review of literature].
    De Martino C; Martino A; Giamattei RM; Viola G; Pisapia A; Fatigati G
    Ann Ital Chir; 2011; 82(5):399-404. PubMed ID: 21988049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Endres M; Haeusler KG; Vajkoczy P; Ringleb PA; Purrucker J; Rizos T; Erbguth F; Schellinger PD; Fink GR; Stetefeld H; Schneider H; Neugebauer H; Röther J; Claßen J; Michalski D; Dörfler A; Schwab S; Huttner HB;
    Ann Neurol; 2018 Jan; 83(1):186-196. PubMed ID: 29314216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of Transcatheter Arterial Embolization with a Modified N-Butyl Cyanoacrylate Glue for Spontaneous Iliopsoas and Rectus Sheath Hematomas in Anticoagulated Patients.
    Jawhari R; Chevallier O; Falvo N; d'Athis P; Gehin S; Charles PE; Midulla M; Loffroy R
    J Vasc Interv Radiol; 2018 Feb; 29(2):210-217. PubMed ID: 29056401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bleeding complications with oral anticoagulants in the elderly: an observational study.
    Peeterbroeck J; Danguy C; Lelubre C; Meulemans M; Higuet S
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Dec; 14(4):406-412. PubMed ID: 27507064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
    Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
    Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
    Maura G; Billionnet C; Alla F; Gagne JJ; Pariente A
    Pharmacotherapy; 2018 Jan; 38(1):6-18. PubMed ID: 29028119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the risk of postoperative bleeding complications in hand surgery without interruption of anticoagulant Vitamin K Antagonist (VKA), a retrospective study].
    Gerenton B; Moris V; Shipkov H; Regnard PJ; Guillier D
    Ann Chir Plast Esthet; 2019 Apr; 64(2):189-194. PubMed ID: 30327208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral iliopsoas hematomas complicating anticoagulant therapy.
    Wada Y; Yanagihara C; Nishimura Y
    Intern Med; 2005 Jun; 44(6):641-3. PubMed ID: 16020897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
    Tsivgoulis G; Lioutas VA; Varelas P; Katsanos AH; Goyal N; Mikulik R; Barlinn K; Krogias C; Sharma VK; Vadikolias K; Dardiotis E; Karapanayiotides T; Pappa A; Zompola C; Triantafyllou S; Kargiotis O; Ioakeimidis M; Giannopoulos S; Kerro A; Tsantes A; Mehta C; Jones M; Schroeder C; Norton C; Bonakis A; Chang J; Alexandrov AW; Mitsias P; Alexandrov AV
    Neurology; 2017 Sep; 89(11):1142-1151. PubMed ID: 28814457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.